| Columbus Speech & Hearing Center | |
|
2424 Double Churches Rd, Columbus, GA 31909-2741 | |
| (706) 324-6112 | |
| (706) 596-8259 |
| Full Name | Columbus Speech & Hearing Center |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 2424 Double Churches Rd, Columbus, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467576140 | NPI | - | NPPES |
| 000636171A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 062134 (Georgia) | Secondary |
| 235Z00000X | Speech-language Pathologist | 062134 (Georgia) | Primary |
| Provider Name | Ashley H Clements |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1427152107 PECOS PAC ID: 6305915034 Enrollment ID: I20080520000805 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Grace Susie Coram Ford |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1912024035 PECOS PAC ID: 7810052974 Enrollment ID: I20101202001142 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Andrea H Webster |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1346214608 PECOS PAC ID: 1759578776 Enrollment ID: I20101202001317 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Alice Cellino |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1285880351 PECOS PAC ID: 9638234792 Enrollment ID: I20110603000576 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | April Mcfarland |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1720120991 PECOS PAC ID: 0143486704 Enrollment ID: I20120725000981 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Rebecca H Sigman |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1275958407 PECOS PAC ID: 5294968251 Enrollment ID: I20140429001373 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Leah Brynn Miller |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1831644772 PECOS PAC ID: 4688969884 Enrollment ID: I20160826002199 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Caitlyn Elizabeth Barfield |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1578028643 PECOS PAC ID: 6507107398 Enrollment ID: I20190403003269 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Rachael Elise Pennock |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1942862545 PECOS PAC ID: 6507196367 Enrollment ID: I20190923000993 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Rachel Lynn Robertson |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1124649132 PECOS PAC ID: 7113358052 Enrollment ID: I20200511000580 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Jessica Lee Argue |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1447873054 PECOS PAC ID: 5193146256 Enrollment ID: I20200528002641 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Jessica Elizabeth Lidvall |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1316455025 PECOS PAC ID: 0143641597 Enrollment ID: I20200610003381 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Anna-maria Palma Barnes |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1841800893 PECOS PAC ID: 1153747886 Enrollment ID: I20200812002271 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Elizabeth A Wall |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1255992962 PECOS PAC ID: 3274959754 Enrollment ID: I20200813003428 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Haley Parker Benn |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1417515388 PECOS PAC ID: 8426478868 Enrollment ID: I20201023000615 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Elizabeth Ann Colberg |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760088520 PECOS PAC ID: 9032525415 Enrollment ID: I20210310000009 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Lindsey Kay Custer |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1124243696 PECOS PAC ID: 3870993561 Enrollment ID: I20210617001097 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Whitney Jenee Ligon |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1992479877 PECOS PAC ID: 6305240425 Enrollment ID: I20210811000656 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Alexis Le'kris Jones |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1841952314 PECOS PAC ID: 3870981046 Enrollment ID: I20211021001300 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Alyssa Corrine Romero |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1871257832 PECOS PAC ID: 6709274384 Enrollment ID: I20211101002559 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Nicole Michele Cooper |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1720564396 PECOS PAC ID: 3577954262 Enrollment ID: I20220107001164 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Ashley Breann Ahrens |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1831736982 PECOS PAC ID: 5395139125 Enrollment ID: I20220222000097 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Emma Kerr Decarlo |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1467190850 PECOS PAC ID: 1355729476 Enrollment ID: I20220602000245 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Heather Payton Melissa Peterson |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1598494494 PECOS PAC ID: 0244619708 Enrollment ID: I20220614002078 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Hayes Vinson Giddens |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1548991490 PECOS PAC ID: 2062892532 Enrollment ID: I20220630002359 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Kayla Savannah Hadden |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1457064057 PECOS PAC ID: 0446620504 Enrollment ID: I20230105002336 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Hannah Jane Knight |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1821679150 PECOS PAC ID: 3971969510 Enrollment ID: I20230524000124 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Kristen Allison Ouzts |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1568155224 PECOS PAC ID: 6608234810 Enrollment ID: I20230621000813 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Provider Name | Susan Marie Fowler |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1285822965 PECOS PAC ID: 9638531494 Enrollment ID: I20230811000574 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Columbus Speech & Hearing Center 2424 Double Churches Rd, Columbus, GA 31909-2741 Ph: (706) 324-6112 | Columbus Speech & Hearing Center 2424 Double Churches Rd, Columbus, GA 31909-2741 Ph: (706) 324-6112 |
News Archive
In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.
The hustle and bustle of finding that perfect gift, crowded retail stores and backing cookies sometimes cloud the true celebration of the Holidays. The Pennsylvania Association for the Blind doesn't want you to forget "It's the Most Wonderful Time of the Year," and wants you to spend it safely with your family.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.
The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.
› Verified 7 days ago
Brittni Irene Dickenson, MED-CSD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2424 Double Churches Rd, Columbus, GA 31909 Phone: 706-324-6112 Fax: 706-596-8259 | |
Lori Sprayberry Morgan, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2424 Double Churches Rd, Columbus, GA 31909 Phone: 706-324-6112 Fax: 706-596-8259 | |
Procom Speech-language Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3645 Gentian Blvd Ste 3b, Columbus, GA 31907 Phone: 706-457-3883 Fax: 706-243-4985 | |
Allison Shannon Ganus, MCD CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2424 Double Churches Rd, Columbus, GA 31909 Phone: 706-324-6112 Fax: 706-596-8259 | |
Joanna Boone Caldwell, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 17th St, Suite 407, Columbus, GA 31901 Phone: 706-321-0930 | |
Heather Neely, M.S., CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2515 Double Churches Rd, Columbus, GA 31909 Phone: 706-660-5495 | |
Natalie Njotu, MS.CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1555 Doubletree Dr, Columbus, GA 31904 Phone: 706-406-4088 |